Record Revenue, Punishing Reaction
Lam Research was trading at $234.59 as of 22 October 2026, down -9.88% on the day, after the company's October 21 earnings call delivered a result that the market treated as a warning rather than a win.
The company posted record September-quarter revenue of $8.22 billion, up 54.4% year over year, and non-GAAP earnings of $2.20 per share — both ahead of consensus estimates, according to finance.yahoo.com. Yet the selloff began before the open on October 22, triggered by CFO Doug Bettinger's remark that December-quarter revenue guidance of $8.6 billion "would have been a bit higher if not for some near-term supply chain constraints." He did not quantify the shortfall. The company also flagged that China's share of revenue, which rose to 35% in the September quarter from 26% in June, is expected to be meaningfully down in December.
Those two signals — a capped near-term outlook and a shrinking China contribution — were enough to send the stock down as much as 10% intraday and pull the broader chip-equipment sector with it. The PHLX Semiconductor Index fell sharply, breaking below a support level that had held twice since September, and peer equipment names dropped alongside Lam.
On the October 21 call, CEO Tim Archer said the supply tightness was "nothing like" COVID-era shortages and that "we'll be caught up very shortly," according to 247wallst.com and AOL. Lam also said it expects the tools delayed from the December quarter to ship in the March quarter, per tikr.com. Those assurances did not arrest the selloff.
The company's preliminary outlook for wafer fabrication equipment spending exceeds $200 billion in calendar 2027, well above the mid-$150 billion range it projects for 2026. The concern weighing on the stock is whether supply constraints — which the company has acknowledged could persist into 2027 — will limit Lam's ability to capture that demand.
A Six-Month High That Now Looks Distant
The move extends a difficult stretch for the stock. Over the past six months, Lam touched a high of $438.07 before pulling back; the current price sits well below that peak, and the six-month change has turned negative.
The one-month picture is similarly bruising, with the stock extending a decline that had already been building before the earnings call. The record quarterly operating margin and the bullish 2027 wafer fab equipment outlook offered a longer-term counterweight, but neither was sufficient to offset the near-term guidance disappointment on the day.
March Quarter Shipments Are the Next Test
The clearest near-term catalyst is the March quarter, when Lam has said it expects to ship the tools delayed from December. The company has also cautioned that supply constraints could persist into 2027, meaning the shipment timeline and the constraint timeline are not the same question — and how the latter resolves will determine how the guidance narrative evolves.
A secondary watch point is the China revenue share. Management's expectation of a meaningful decline in December sets a bar that, if missed in either direction, could move the stock again when the next quarterly report arrives.
Risk Factors
- Volatility risk: A single-session decline of -9.88% signals elevated short-term price swings; further sharp moves in either direction are plausible as the market digests the supply constraint narrative.
- Supply chain duration risk: Lam expects the tools delayed from the December quarter to ship in the March quarter, but has acknowledged that supply constraints could persist into 2027 — a distinction the market appears to be pricing in.
- China revenue concentration risk: China rose to 35% of revenue in September and is guided meaningfully lower in December; a sharper-than-expected drop or additional trade restrictions could amplify the revenue shortfall.
- Sector contagion risk: The selloff spread across chip-equipment peers on October 22; if broader semiconductor sentiment deteriorates, Lam may face additional selling pressure independent of its own fundamentals.
This article does not constitute financial advice. It is intended for informational purposes only. Past performance is not indicative of future results. Investors should conduct their own research before making any investment decisions.
This article was generated with AI assistance and may contain errors.
TiMi AI